Linfritz Research Institute

Linfritz Research Institute is a private clinical research site organization in Coral Gables, Florida that appears to operate under the assumed name Linfritz Research Center. The business participates as an investigator site in industry-sponsored clinical trials rather than developing its own proprietary drug pipeline. Publicly visible evidence links the site to enrollment in late-stage studies including lecanemab for early Alzheimer's disease and earlier cardiovascular/metabolic studies such as bococizumab in hyperlipidemia. Based on available records, it functions as a healthcare-related research company focused on conducting clinical studies for external sponsors and investigators.